Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03522298
Title Safety, Pharmacokinetics and Efficacy of GDC-0084 in Newly-diagnosed Glioblastoma Multiforme
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kazia Therapeutics Limited
Indications

brain glioblastoma multiforme

Therapies

GDC-0084

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.